Short answer. Collecting seed from farmers and selling the descendants isn't automatically biopiracy, but doing it without the source country's permission, the community's consent or any share of the benefits is what the term means. Since the Convention on Biological Diversity (1992), countries hold sovereign rights over their genetic resources, and the Nagoya Protocol (in force 2014) spells out the rules: prior informed consent, mutually agreed terms and fair benefit-sharing [1][2]. Cannabis mostly slips past them: it isn't on the Plant Treaty's crop list [3], it remains a Schedule I drug [7][8], most seed in circulation was collected before these rules existed, and neither the US nor Canada is a Nagoya party [1][2]. The law hasn't caught up. Practice can.
House position (founder's view): a strong yes on benefit-sharing. The farmers who selected the world's landraces over centuries deserve credit and compensation, and anyone collecting from them should do it with consent. That's a value, not a legal summary: as below, the law often doesn't require it for cannabis. We think it should be done anyway.
What "biopiracy" means
There's no single legal definition. In policy use it means taking genetic resources or the traditional knowledge attached to them, then commercialising or patenting the result, without consent from, credit to or benefit for the people and country they came from. Two separate wrongs often travel together: taking without permission (an access problem) and claiming as new what a community already knew or bred (a patent and credit problem).
The rules, in one table
| Instrument | What it does | Who's in (as of October 2026) |
|---|---|---|
| Convention on Biological Diversity (1992; in force 29 December 1993) [1] | States have sovereign rights over their genetic resources. Access needs the provider country's prior informed consent (Art. 15(5)) on mutually agreed terms (Art. 15(4)), with fair sharing of benefits. Art. 8(j) protects Indigenous and local communities' traditional knowledge | 196 Parties. The US signed (1993) but never ratified. Canada ratified in 1992 |
| Nagoya Protocol (adopted 2010; in force 12 October 2014) [2] | Makes CBD access and benefit-sharing (ABS) operational: benefit-sharing (Art. 5), PIC (Art. 6), community consent for traditional knowledge (Art. 7), user-country compliance checks (Arts. 15-17). "Utilisation" means research and development on a resource's genetic or biochemical make-up; breeding counts | 143 Parties. In: EU, India, South Africa, Mexico, Pakistan (2016), Lebanon (2018), Afghanistan (2018), Nepal (2019), Morocco (2022). Not in: US, Canada, Jamaica. Colombia and Thailand signed but haven't ratified |
| EU Regulation 511/2014 [6] | Users in the EU must exercise due diligence that genetic resources they use were accessed legally under the provider's ABS law | EU member states |
| Plant Treaty (ITPGRFA) (2001; in force 2004) [3] | A shared pool for 64 food and forage crops (Annex I) under a standard transfer agreement | Cannabis is not in Annex I, so the Treaty's ready-made system doesn't cover it |
| CBD Decision 16/2 and the Cali Fund (COP16, 2 November 2024; fund launched 25 February 2025) [4] | A global fund for benefits from digital sequence information (genome data). Large users are expected to pay an indicative 1 % of profits or 0.1 % of revenue; at least 50 % goes to Indigenous peoples and local communities [4][5] | Voluntary. By August 2026 it had two confirmed contributions totalling US$6,000, against an expected US$1 billion a year [5] |
| WIPO treaty on IP, genetic resources and traditional knowledge (adopted 24 May 2024) [16] | Patent applicants must disclose the origin of genetic resources or traditional knowledge an invention is based on | Not yet in force: it needs 15 ratifications.being reviewed |
Why cannabis falls through the cracks
- It's still a controlled drug. Cannabis and cannabis resin remain in Schedule I of the 1961 Single Convention; the 2020 vote only removed them from Schedule IV (27 votes to 25, one abstention) [7][8]. An ABS permit doesn't make an export legal, and drug law doesn't grant access rights. Collecting and moving cannabis material lawfully needs both, and in most source countries the drug-law side has been closed for decades, so nearly every landrace in circulation was technically collected outside the law. The treaty definition of "cannabis" excludes seeds not accompanied by the tops [7], but national laws on seed vary widely. Check local rules before collecting, carrying or importing any plant material.
- Most seed was collected before the rules. The bulk of "landrace" seed in Western catalogues was gathered on travels in the 1960s to 1980s, before the CBD's 1993 entry into force. ABS law is generally not applied retroactively, and the CBD's start date is commonly treated as the threshold [9]. Whether later breeding of old collections counts as new utilisation is debated.
- Widespread material may be out of scope. Analysts of the coffee sector note that old, globally disseminated varieties are generally treated as outside Nagoya's reach [9]. Heirloom cannabis lines grown worldwide for decades are in the same position.
- Big user countries aren't bound. The US isn't a CBD party and neither the US nor Canada has joined Nagoya [1][2], so no user-country compliance check applies there.
- Genome data moves freely. Landrace sequences in public databases are digital sequence information. The Cali Fund exists for exactly this, but payment is voluntary and, so far, close to nil [4][5].
Source countries: a snapshot
| Country | What applies | Notes |
|---|---|---|
| Morocco | Law 13-21 (2021) allows medical and industrial cannabis under a state regulator (ANRAC); non-medical products above 1 % THC barred [14]. Nagoya Party since 2022 [2] | In 2024 the regulator approved the local variety, Beldia, for licensed cooperatives; it made up 2,786 of 4,082 tonnes of the 2024 legal harvest [15]. A source country putting its own landrace first |
| India | Biological Diversity Act 2002 (amended 2023): foreign users need national approval to access biological resources and associated knowledge. Nagoya Party [2] | being reviewed |
| South Africa | Biodiversity Act 2004, Chapter 6, and the Bioprospecting, Access and Benefit-Sharing Regulations (2008). Nagoya Party [2] | The legal home of the hoodia and rooibos agreements below [12][13] |
| Afghanistan, Pakistan, Nepal, Lebanon | Nagoya Parties since 2016-2019 [2] | Drug law makes lawful collection of cannabis material effectively impossible |
| Colombia, Jamaica, Thailand | CBD Parties, not Nagoya Parties [1][2]; each has a licensed cannabis regime | being reviewed |
Precedents: what credit and compensation look like
None of these are cannabis, but they are the public cases the field learned from.
| Case | What happened |
|---|---|
| Turmeric | A 1995 US patent (5,401,504) claimed turmeric for wound healing. India's Council of Scientific and Industrial Research challenged it with prior art including a 1953 Indian medical journal paper; the US Patent Office rejected all claims in 1997 [10] |
| Neem | A European patent on a neem-oil fungicide was revoked in 2000 after opposition; the Board of Appeal dismissed the appeal in 2005 for lack of inventive step [11] |
| Hoodia | After an appetite-suppressant compound from hoodia, long used by San people, was patented and licensed without them, a 2003 agreement gave San communities 6 % of royalties and 8 % of milestone payments, paid into a trust [12] |
| Rooibos | A 2019 agreement under South Africa's ABS rules requires processors to pay a levy of 1.5 % of the farm-gate price to Khoi and San communities for their traditional knowledge, estimated at about R12 million a year [13] |
The lesson: patents on traditional knowledge can be beaten with documented prior art, and benefit-sharing works when it's written into law and contracts.
The cannabis practices
Described as practices, because that's what the record supports:
- Seed collected on travels and sold as "landrace" decades later, after generations of selection and sometimes crossing elsewhere. That's an heirloom, not a landrace, and the farmers are rarely named (see landraces of the world, especially its Credit where it's due section).
- Country names as marketing. A region in a name is a claim, not provenance.
- Protection filed on landrace-derived material. Plant patents, utility patents and breeders' rights can cover lines and traits whose roots are farmer selections; all are public records (see patents and the gene pool).
- Erosion at source. While collected seed is sold abroad, the domesticates at home are endangered by hybrid replacement [17]. Taking without giving back speeds the loss.
What fair practice looks like
- Know the law. Where a national ABS permit or drug-law licence is available, get it. Because cannabis collection has been technically illegal almost everywhere, legality alone can't be the test of fair practice; consent, credit and returning value are. GenetixBay doesn't advise anyone to break the law where they live.
- Prior informed consent from the community, in their language, before collecting, including what the material will be used for and whether it may be sold or protected.
- Mutually agreed terms in writing: what is shared, how much, for how long.
- Credit by name: region, community and, where they wish, the farmers. Not "Asian landrace", but the valley and the people.
- Compensation: a share of seed sales, a fixed payment, or funding the community wants, such as a community seed bank.
- Share seed back. Return seed and records to the community and to public gene banks where legal, so a collection doesn't become the only copy.
- Document everything: collection place and date, collector, number of seeds or plants, permits, and how the line has been maintained since.
- Don't patent what you collected. Prior art belongs to the people who bred it.
GenetixBay's position
We don't gatekeep the archive on how seed was collected decades ago: cannabis collection has been technically illegal almost everywhere for generations, so that test would erase nearly every landrace. What we ask for instead is credit and honesty.
- Credit the source on every record. Landrace populations get their own record type (GB-LRC) with region of origin, keeper or custodian, collection history and evidence level, and every line descended from one carries the source region and community credit forward.
- Document provenance honestly. Collection place and date, collector and maintenance history are evidence-graded claims (L0-L4; see documenting lineage evidence). Unknown stays unknown; we label collected-and-maintained lines as heirloom, not landrace.
- Encourage benefit-sharing and fair practice. Consent, written terms, compensation and sharing seed back are the standard we promote, whether or not a treaty forces it.
- Reward returning value. Breeders and members who return seed, records or money to source communities earn recognition on the platform for it.
Common mistakes
- "It was legal to buy, so it's ethical." Access law, drug law and ethics are three different questions.
- "Nagoya doesn't apply, so nothing is owed." The law is a floor.
- "Old seed is fair game." It may be outside the law; the credit is still owed.
- Encouraging anyone to smuggle seed. Never.
Evidence
- CBD and Nagoya obligations (PIC, MAT, benefit-sharing) and party status: Established (treaty texts and official lists) [1][2].
- Cannabis absent from Plant Treaty Annex I: Established [3].
- Cannabis in Schedule I of the 1961 Convention: Established [7][8].
- Cali Fund rates, voluntary status and low uptake: Established for the decision [4]; Supported for uptake (press report) [5].
- Pre-CBD and widespread material falling outside ABS: Supported, with legal debate [9].
- Turmeric, neem, hoodia and rooibos outcomes: Established (public decisions and agreements) [10]-[13].
- Morocco's Beldia programme: Supported (press reports of regulator data) [14][15].
- Source communities deserve credit and compensation beyond what the law requires: founder's view.
Biopiracy is taking genetic resources or traditional knowledge from a country or community without consent or benefit-sharing, especially to patent or profit from them.Germplasm is living genetic material (seeds, pollen, tissue or plants) kept for breeding, research or conservation, representing the genetic diversity of a crop.The Nagoya Protocol is a 2010 international treaty under the Convention on Biological Diversity governing access to genetic resources and fair sharing of their benefits.Prior informed consent is permission given in advance, with full information about intended use, by a country or community before its genetic resources or knowledge are accessed.Benefit-sharing is returning a fair share of the benefits from using genetic resources or traditional knowledge, money, credit, access or support, to the people who provided them.Scheduling is placing a substance in a legal category of a drug-control law or treaty, which sets how strictly it is controlled and whether medical use is recognised.A landrace is a traditional, locally adapted cannabis population kept by farmers in one region over many generations, with its own type and plenty of internal variation.CBD (cannabidiol) is a non-intoxicating neutral cannabinoid formed when CBDA decarboxylates; hemp-type and CBD-dominant cannabis make it mainly as CBDA in their trichomes.The 1961 Single Convention on Narcotic Drugs is the UN treaty that obliges parties to control cannabis and other listed drugs, limiting them to medical and scientific use.An heirloom is a seed line kept and passed down by growers for decades, usually outside its region of origin, preserving an older type rather than a recent hybrid.An oil pressed from seeds of the neem tree (Azadirachta indica) that smothers soft-bodied pests and, in crude forms, contains azadirachtin, an insect growth disruptor.A plant patent, in the US, protects a new and distinct asexually reproduced plant variety, such as a clone, for about 20 years from filing.A utility patent protects a new, useful and non-obvious invention; for plants it can cover varieties, seeds, specific traits or breeding and processing methods.Plant variety protection (plant breeders' rights) is an intellectual property right for a new plant variety that is distinct, uniform and stable, typically 20-25 years.In cannabis slang, a seed bank is a vendor that sells seed from one or many breeders; it is not the same as a conservation genebank.A gene is a stretch of DNA that carries the instructions for one functional product, usually a protein such as an enzyme, and is the basic unit of inheritance.
